Skip to main navigation
Scientists Patients Medical Professionals Investors and Media Careers
 logo
  • News
  • Events
  • Stock
  • Financials
  • Governance
  • FAQs
    • Scientists
    • Patients
    • Medical Professionals
    • Investors and Media
    • Careers

INVESTORS & MEDIA

Event

Events & Presentations
Archived Presentations

Regeneron Oncology Investor Event, ASCO 2020

Jun 12020 4:30 PM EDT Jun 1, 2020 | 4:30 PM EDT

listen to webcast

Supporting Materials

Regeneron Oncology Investor Event, ASCO 2020 Presentation 2.2 MB
Trial in Progress - Phase 1-2 for REGN5093 (METxMET) in MET-Altered Advanced NSCLC 1.1 MB
Trial in Progress - Phase 1-2 for REGN5678 (PSMAxCD28) in mCRPC 1.3 MB
Trial in Progress - Phase 3 for Libtayo in Adjuvant CSCC 218.1 KB
Phase 2 of Libtayo in Advanced CSCC - Post Hoc Exploratory Analysis 142.7 KB
Phase 2 of Libtayo in Advanced CSCC - Three-year follow-up 132 KB
Email Alerts
RSS Newsfeed
Share This Page
Search
Regeneron logo
  • Twitter logo
  • LinkedIn logo
  • Facebook logo
  • Instagram logo
  • YouTube logo
  • Terms of Use
  • Contact Us
  • Site Map
  • Social Media Terms of Engagement
  • Privacy Notice
  • Accessibility Statement
  • Investors and Media
  • Careers
  • Ireland
  • Covid-19 Antibody Program

Copyright © 2023 Regeneron Pharmaceuticals Inc. All rights reserved. All trademarks mentioned are the property of their respective owners.

Back to top

Investors & Media

  • Facebook
  • LinkedIn
  • Twitter
  • RSS Feeds

You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

Continue

You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

Continue